Fed's Capital Easing Offers Modest Tailwind for BAC, But NII Sensitivity Remains Key

What happened

The Federal Reserve has proposed lowering capital buffers for banks, potentially freeing up lending capacity and supporting growth. For Bank of America, this regulatory shift could ease some capital constraints, such as AOCI pressures under Basel 3, noted in the DeepValue report. However, BAC's investment thesis remains tightly tied to net interest income growth and operating leverage, with asymmetric sensitivity to rate changes. While reduced buffers might aid loan expansion and capital returns, the core drivers of NII and expenses are unchanged. Investors should see this as a marginal positive, but the stock's near-term trajectory still depends on 1Q26 results confirming FY26 targets.

Implication

Lower capital buffers may enhance BAC's lending flexibility, potentially supporting earnings through increased loan volumes. This could modestly improve capital return prospects, such as buybacks, by easing regulatory constraints. However, the primary investment case relies on achieving FY26 NII growth of +5% to +7% and ~200 bps operating leverage. The asymmetric NII sensitivity to rate changes remains a critical risk, unaffected by capital buffer adjustments. Therefore, while the regulatory change is favorable, investors should maintain a cautious stance until 1Q26 results validate the earnings trajectory.

Thesis delta

The Fed's capital reset does not materially alter the core investment thesis for BAC, which is centered on NII performance and expense management. It offers minor upside through improved capital flexibility, but the key catalysts remain the 1Q26 deposit cost and expense prints. No shift from the 'WAIT' rating is justified until fundamental progress is demonstrated.